Showing results (201-210 of 266) with videos related to
Sort By:
Pageof 27
Journal of Crohn'S & Colitis|August 10, 2020
Gut microbial transcytosis induced by tumor necrosis factor-like 1A-dependent activation of a myosin light chain kinase splice variant contributes to IBDYu-Chen Pai, Li-Ting Weng, Shu-Chen Wei, et al.Scientific Reports|August 1, 2020
Elafin inhibits obesity, hyperglycemia, and liver steatosis in high-fat diet-treated male miceJiani Wang, Christina Ortiz, Lindsey Fontenot, et al.Gastroenterology|April 17, 2012
Abatacept for Crohn's disease and ulcerative colitisWilliam J Sandborn, Jean-Frederic Colombel, Bruce E Sands, et al.Inflammatory Bowel Diseases|April 23, 2016
TNFRSF1B Is Associated with ANCA in IBDDalin Li, Mark S Silverberg, Talin Haritunians, et al.Inflammatory Bowel Diseases|March 11, 2011
Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behaviorGary R Lichtenstein, Stephan R Targan, Marla C Dubinsky, et al.Gastroenterology|May 21, 2025
Fidaxomicin Reduces Collagen Expression in Intestinal Fibroblasts Via Platelet-Derived Growth Factor Receptor Beta and Glycogen Synthase Kinase-3 Beta InhibitionSophie Irwin, Mieke van Daelen, Isabella Almaraz, et al.Gastroenterology|May 9, 2007
Natalizumab for the treatment of active Crohn's disease: results of the ENCORE TrialStephan R Targan, Brian G Feagan, Richard N Fedorak, et al.Inflammatory Bowel Diseases|June 8, 2017
Colonic Phenotypes Are Associated with Poorer Response to Anti-TNF Therapies in Patients with IBDSoon Man Yoon, Talin Haritunians, Sultan Chhina, et al.Frontiers in Immunology|July 11, 2022
BATF3 Protects Against Metabolic Syndrome and Maintains Intestinal Epithelial HomeostasisHussein Hamade, Jasmine T Stamps, Dalton T Stamps, et al.Journal of Clinical Gastroenterology|December 13, 2005
Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's diseaseMaria T Abreu, Jordan L Geller, Eric A Vasiliauskas, et al.Pageof 27